Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss ...

Alcon (ALC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Deerfield Management accused Alcon of obstructing Aurion’s IPO plans so it could acquire the startup “at a discount.” ...

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a ...

KeyBanc analyst Brett Fishbin raised the firm’s price target on Alcon (ALC) to $112 from $108 on higher multiple, while keeping an Overweight ...

Deutsche Bank raised the firm’s price target on Alcon (ALC) to CHF 96 from CHF 92 and keeps a Buy rating on the shares.Don't Miss Our End of ...

Alcon will expand its femtosecond laser-assisted cataract surgery offerings with a deal to acquire Lensar, according to a ...

Alcon said that its majority stake means that Aurion will have "broader R&D, regulatory, medical ophthalmic, and commercial ...

Alcon has signed a definitive merger agreement to acquire Lensar to enhance its portfolio of cataract equipment and ...

In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Alcon (ALC – Research Report), with a price target of $112.00. The company’s shares closed la ...

Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as a separate ...

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser ...